dr. catenacci on study of margetuximab plus pembrolizumab in gastric:gej cancer
Published 6 years ago • 114 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:38
dr. catenacci on results of margetuximab plus pembrolizumab in gastric/gej cancer
-
3:11
daniel catenacci, md, discusses margetuximab in the treatment of esophageal and gastric cancer
-
2:00
dr. catenacci on the challenges of developing novel therapies in gastroesophageal cancer
-
2:21
dr. catenacci on treatment selection in esophagogastric junction adenocarcinoma
-
1:33
dr. fuchs discusses immunotherapy in gastric cancer
-
25:16
gastric cancer updates
-
1:45
dr. pegram on a phase ii trial of mgah22 in breast cancer
-
2:19
immunotherapy: what you need to know
-
0:58
dr. machiels on pembrolizumab in head and neck cancer
-
1:14
dr. ahn on the role of immunotherapy in treating patients with gastric/gastroesophageal cancers
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer
-
10:16
ongoing research in gastric cancer; antiangiogenic therapy upfront and immunotherapy
-
1:06
pancreatic cancer awareness month
-
2:29
overcoming resistance to immunotherapy as first-line therapy in gastric cancer
-
0:52
oncotarget: onc201, trail, and breast cancer
-
4:13
clinical trials: what you need to know
-
2:37
developments in gastric and gastroesophageal cancer management
-
1:08
ascent-05: sacituzumab govitecan and pembrolizumab in tnbc
-
1:21
charles cagin, d.o., cardiology - mayo clinic health system